Search

everythinglearnresearchcommunity

for

Search:↓

Most men with lichen planopilaris had it confirmed by biopsy and often had thyroid issues, sexual dysfunction, or prostate cancer, hinting at a link with hormonal problems.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

Early balding may be a sign of future prostate problems.

Urinary PSA could be an early marker for enlarged prostate.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

The compound was successfully made and shows potential for treating prostate cancer.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Shorter PSADT after prostate surgery is linked to higher risk of death.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Androgen-modulating drugs do not significantly change the heat sensitivity of prostate cancer cells.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

There is no link between hair loss and prostate enlargement.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Hair loss can be an early sign of prostate enlargement.

People with early-onset hair loss (AGA) have a higher risk of heart disease, metabolic syndrome, and prostate enlargement.

Finasteride affects prostate weights and pituitary activity differently with age.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

All treatments helped with prostate symptoms, but the combination of dibenyline and finasteride worked best without extra side effects.

Pumpkin seed oil may improve prostate health, bladder control, and hair growth in men.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Finasteride may help reduce inappropriate sexual behaviors in dementia patients with prostate issues.

New Finasteride conjugate improves prostate treatment and vital signs in rats.